Online Pharmacy, Tramadol, Paxil, antibiotics, amoxicillin, zithromax, Rx Online, pharmaceuticals, DHEA, prescription medications, prescription drugs.

Drugs online research references

Antibiot Khimioter. 2001;46(6):27-31.
[Candidosis of the central nervous system in children of the first year--one of the problems in nosocomial fungal infections]

[Article in Russian]

Buslaeva GN.

Russian State Medical University, Moscow.

CNS candidosis is a severe disease, one of the nosocomial fungal infections, with often lethal issue or invalidation of the patient. Specific signs are absent and early diagnosis is very difficult. Risk factors are the following: prematurity, candidal carriage, prolonged hospitalization, treatment with broad spectrum antibiotics and immunosupressors, artificial pulmonary ventilation. No single effective antifungal agent exists. In the case of acute fungal CNS infection the drug of choice is fluconazole (diflucan) characterized by high efficacy and CSF sanitation rate, the drug is used intravenously with possible switching off to oral form. If the pathogen is not susceptible to the drug (C. crusel, C. glabrata and C. tropicalis) amphotericin B is recommended (C. lusitaniae is not susceptible). In the case of renal or hepatic failure AmBisome may be used as less toxic form. If the case of prolonged disease antifungal drugs are used in a long-term regime, drugs combinations are also recommended. Complex therapy with granulocyte colony stimulating factor may be used if the previous regime was not effective.

online pharmacy ref source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11573321&dopt=Abstract

rfc.ucl.ac.uk

The availability of an improved oral solution and an intravenous (IV) formulation of itraconazole (Sporanox) promises to have an effect on prevention and treatment of fungal infection in immunocompromised patients. Use of itraconazole in neutropenic patients with hematologic malignancies has been evaluated in a number of European studies. Treatment with IV followed by oral itraconazole resulted in response or stable disease in two-thirds of patients with invasive pulmonary aspergillosis. Empiric treatment with IV followed by oral solution itraconazole was at least as effective as, and significantly less toxic than, amphotericin B. Several studies of oral solution prophylaxis indicate effectiveness in prevention of fungal infection. Oral solution and IV itraconazole are useful in a variety of situations in prophylaxis, empiric therapy, and treatment of probable/confirmed infection. Itraconazole exhibits a broad spectrum of activity against Aspergillus and Candida species. It has potential advantages over fluconazole (Diflucan), which does not exhibit in vitro activity against Aspergillus and most non-albicans Candida species, and amphotericin B, which is associated with a high incidence of toxicity. Aggressive use of itraconazole and amphotericin B preparations in treatment of fungal infection at Royal Free Hospital may have reduced mortality associated with aspergillosis.

online pharmacy ref source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11757848&dopt=Abstract

Arzneimittelforschung. 1995 Jul;45(7):819-21.
Comparison of the in vitro activity of fluconazole against Candida albicans and dermatophytes.

Wildfeuer A, Seidl HP.

Pfizer/Mack, Illertissen, Germany.

Fluconazole (CAS 86386-73-4, Diflucan, Fungata is an antimycotic agent of established value in the treatment of systemic infections with yeasts; more recently this drug has been used in the oral treatment of dermatomycoses. The in vitro activity of fluconazole against 51 strains of C. albicans and 207 isolates of four different species of dermatophytes was therefore measured and the results collated. The mean minimal inhibitory concentrations (MIC) show that in vitro fluconazole is a significantly stronger inhibitor of the proliferation of C. albicans (0.34 micrograms/ml) than of the dermatophytes T. rubrum (6.4 micrograms/ml), T. mentagrophytes (23.9 micrograms/ml), M. canis (18.3 micrograms/ml) and E. floccosum (3.5 micrograms/ml). On the other hand, the distribution of the MIC values shows that the sensitivity to fluconazole within a single species is also very variable. It is evident that the concentrations of fluconazole reached particularly in the stratum corneum of the skin after oral therapy are adequate to inhibit the growth of the yeasts and of the dermatophytes examined.

online pharmacy ref source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8573230&dopt=Abstract

online pharmacies || Hair Million herbal formula for hair loss and hair growth || Tramadol || Antibiotics and prescription medications online literature || Antibiotics